PTC Therapeutics Granted Marketing Authorization By EU For Upstaza To Treat AADC Deficiency

RTTNews | 1135 days ago
PTC Therapeutics Granted Marketing Authorization By EU For Upstaza To Treat AADC Deficiency

(RTTNews) - PTC Therapeutics, Inc. (PTCT) announced Wednesday that Upstaza (eladocagene exuparvovec) was granted marketing authorization by the European Commission. Upstaza is the first approved disease-modifying treatment for aromatic L-amino acid decarboxylase (AADC) deficiency and the first marketed gene therapy directly infused into the brain. It is approved for patients 18 months and older.

Upstaza is a one-time gene replacement therapy indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of AADC deficiency with a severe phenotype.

The marketing authorization is applicable to all 27 European Union member states, as well as Iceland, Norway and Liechtenstein.

For More Such Health News, visit rttnews.com

read more
FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the treatment of aromatic L-amino acid decarboxylase or AADC deficiency. Kebilidi is the first FDA-approved gene therapy for the deficiency. PTC shares gained around 8.5 percent in the extended trading on the Nasdaq on Thursday.
RTTNews | 287 days ago
Additional Support Predicted For Indonesia Shares

Additional Support Predicted For Indonesia Shares

The Indonesia stock market has moved higher in two consecutive trading days, gathering almost 50 points or 0.6 percent in that span. The Jakarta Composite Index now sits just above the 7,950-point plateau and it may add to its winnings on Friday.
RTTNews | 13 minutes ago
Australian Market Slightly Lower

Australian Market Slightly Lower

The Australian stock market is trading slightly lower on Friday, giving up some of the gains in the previous two sessions, despite the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 9,000 mark, with weakness in mining and financial stocks partially offset by gains in energy and technology stocks.
RTTNews | 22 minutes ago
Hong Kong Shares May Stop The Bleeding On Friday

Hong Kong Shares May Stop The Bleeding On Friday

The Hong Kong stock market has finished lower in three straight sessions, tumbling almost 830 points or 3.3 percent along the way. The Hang Seng Index now rests just beneath the 25,000-point plateau although it may find traction on Friday.
RTTNews | 28 minutes ago
Higher Open Called For China Stock Market

Higher Open Called For China Stock Market

The China stock market on Thursday snapped the two-day losing streak in which it had stumbled more than 80 points or 2.1 percent. The Shanghai Composite Index now sits just above the 3,840-point plateau and it's expected to see additional support on Friday.
RTTNews | 43 minutes ago
Rebound Anticipated For Taiwan Stock Market

Rebound Anticipated For Taiwan Stock Market

The Taiwan stock market on Thursday wrote a finish to the three-day winning streak in which it had jumped more than 750 points or 3.1 percent. The Taiwan Stock Exchange now rests just beneath the 24,230-point plateau although it figures to bounce higher again on Friday.
RTTNews | 1h 13min ago
Japan Retail Sales Add 0.3% In July

Japan Retail Sales Add 0.3% In July

The value of retail sales in Japan was up a seasonally adjusted 0.3 percent on month in July, the Ministry of Economy, Trade and Industry said on Friday - coming in at 13.335 trillion yen.
RTTNews | 1h 40min ago